Clinical Trial Update: Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

View source ↗

Summary

A prescreening study by Ascidian Therapeutics (STARPATH) to identify potential Stargardt disease participants for ACDN-01 clinical trials; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cone Rod Dystrophy
• Juvenile Macular Degeneration
• Stargardt Disease

Drugs mentioned

• ACDN-01

Snippet

Sponsor: Ascidian Therapeutics, Inc | Conditions: Stargardt Disease, Stargardt Disease 1 | Status: RECRUITING